Tag Archives: BME

Top 5 Casino Stocks To Buy For 2019

Main Thesis

The purpose of this article is to articulate why I believe The Stars Group (NASDAQ:TSG) is an attractive investment option at its current market price. While there are multiple tailwinds on the horizon, the top story is a favorable Supreme Court ruling. This should pave the way for more states in the U.S. to allow online sport gambling, which TSG is uniquely poised to benefit from. Furthermore, TSG recently entered in to an agreement to acquire Sky Betting & Gaming (SBG), a British-based online gaming company. This acquisition will help firm up TSG’s prominence in one of the world’s largest regulated online gaming territories, the United Kingdom. Finally, TSG continues to earn more money year over year, and its reliance on poker is declining, which tells me the company is doing a great job diversifying its revenue base.

Background

First, a little about TSG. TSG is the owner of multiple gaming brands including PokerStars, PokerStars Casino, Full Tilt, Megastack, and BetStars (sports betting), among others, and, most recently, SBG, a British online gambling company. Therefore, TSG controls some of the biggest brands in online gaming. Currently, TSG is trading at $35.85/share and does not pay any dividend. My last review of TSG came in late February, when I strongly recommended to my readers to buy the stock. Since that time, TSG is up over 34%, which is very strong short-term performance. Even more impressive is that this gain came during a time period when the broader market, as measured by the S&P 500, was essentially flat. Given this out-performance, I wanted to reassess the stock to see if now was a good time to take profits, or if it still made sense to remain long. After a review, I continue to be a believer in the company’s long-term story, and I will explain why in detail below.

Top 5 Casino Stocks To Buy For 2019: Macy's Inc(M)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Macys, Inc. (NYSE: M) which traded down about over 4% at $25.64. The stocks 52-week range is $17.41 to $36.93. Volume was over 9 million versus the daily average of 14.2 million shares.

  • [By Jim Crumly]

    As for individual stocks, Macy’s (NYSE:M)helped kicked off the retail earnings season with good results, and Tencent Holdings Limited (NASDAQOTH:TCEHY) reported continued high growth.

  • [By Adam Levine-Weinberg]

    Last week, a pair of Wall Street analysts cautioned investors to steer clear of Macy’s (NYSE:M) stock, warning that poor weather may have undermined its first-quarter sales, causing an early end to Macy’s earnings recovery.

Top 5 Casino Stocks To Buy For 2019: Trustmark Corporation(TRMK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rhumbline Advisers lowered its position in Trustmark Corp (NASDAQ:TRMK) by 5.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 122,924 shares of the financial services provider’s stock after selling 7,773 shares during the quarter. Rhumbline Advisers owned about 0.18% of Trustmark worth $3,830,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Trustmark (TRMK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Trustmark (NASDAQ: TRMK) and Valley National Bank (NYSE:VLY) are both mid-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.

Top 5 Casino Stocks To Buy For 2019: Northern Oil and Gas, Inc.(NOG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Northland Securities assumed coverage on shares of Northern Oil and Gas (NYSEAMERICAN:NOG) in a report published on Wednesday. The firm issued an outperform rating and a $4.00 price target on the energy company’s stock.

  • [By Garrett Baldwin]

    Markets are cheering a major development in efforts to fix the ongoing trade conflict between the United States and China. According to Reuters, Chinese telecom giant ZTE has signed an agreement to get back into business with its American partners. The agreement will lift a ban by the U.S. Commerce Department that prevented China’s No. 2 telecommunications equipment from buying from U.S. suppliers. This is a major development, and one that signals progress among trade officials from both nations. There are now more job openings in the United States than available workers. This is the first time that the Department of Labor has documented this phenomenon. There are 6.7 million openings compared to the 6.4 million workers available to fill those positions. As a result, U.S. companies have been forced to increase compensation in order to attract talent. All of the positive economic development could come to a screeching halt should the U.S. experience the largest labor strike in a decade. Reports indicate that the Teamsters and the United Parcel Service (NYSE: UPS) are on a collision course that could result in a general strike. The union has announced that 260,000 UPS employees have authorized a strike should both sides fail to reach a labor deal by August 1. UPS is responsible for the transport of 6% of the nation’s gross domestic product.
    Three Stocks to Watch Today: TSLA, NOG, WFC
    Tesla Inc. (Nasdaq: TSLA) investors remain committed to giving Chairman Elon Musk more of their money. On Tuesday, shareholders struck down proposals that would have removed Musk from the chairman role and shaken up the board of directors. Both proposals failed. At the same shareholder event, Musk announced plans for Tesla to open a production facility in Shanghai and projected that his firm will likely produce 5,000 Model 3 vehicles per week by the end of June. In deal news, defense contractor Northrop Grumman (NYSE: NOG) has won U.S. antitrust approval to purchase rocket moto

  • [By Ezra Schwarzbaum]

    SunTrust analyst Neal Dingmann upgraded shares of Northern Oil & Gas, Inc. (NYSE: NOG) from Hold to Buy and increased his price target from $2 to $4.

  • [By Matthew DiLallo]

    Shares of Northern Oil & Gas, Inc. (NYSEMKT:NOG) are flying high, up 12% as of 10:30 a.m. EDT, after the company reported better-than-expected first-quarter results.

Top 5 Casino Stocks To Buy For 2019: Banco Santander, S.A.(SAN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Santiment Network Token (CURRENCY:SAN) traded up 2.4% against the US dollar during the 24 hour period ending at 7:00 AM ET on June 14th. One Santiment Network Token token can now be purchased for $0.85 or 0.00013092 BTC on major exchanges including IDEX, LATOKEN, OKEx and Ethfinex. Santiment Network Token has a total market cap of $53.29 million and approximately $586,070.00 worth of Santiment Network Token was traded on exchanges in the last 24 hours. Over the last week, Santiment Network Token has traded down 28.4% against the US dollar.

  • [By Ethan Ryder]

    Whittier Trust Co. of Nevada Inc. lifted its holdings in Santander Group (NYSE:SAN) by 32.6% during the first quarter, Holdings Channel reports. The institutional investor owned 45,610 shares of the bank’s stock after buying an additional 11,224 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Santander Group were worth $299,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    COPYRIGHT VIOLATION WARNING: “Jefferies Group Analysts Give Sanofi (SAN) a €72.00 Price Target” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3353529/jefferies-group-analysts-give-sanofi-san-a-72-00-price-target.html.

Top 5 Casino Stocks To Buy For 2019: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

Hot Low Price Stocks To Invest In 2019

Make way for some waves. CVS Health (CVS) and Express Scripts (ESRX) have released their formulary exclusion list for 2017, which details which prescription drugs will not be covered by health plans.

Why do we care? Commercial payors have been showing signs of pushing back against high drugs costs, which is a huge concern for drug companies and their investors. The coverage list determines whether millions of privately insured individuals can easily use an insurance co-payment to buy their prescriptions. If a drug is excluded, it can dramatically hobble sales.

Thus, the formulary exclusion lists can be used as a tool by insurers and PBMs leverage you might say to negotiate with drug makers for better prices. Its also a double edged sword that can cost a PBM customers.

Express Scripts says it will save customers $1.8 billion in 2017 by excluding a list of 85 drugs from its formulary in 2017. It added a handful of new names to the list, including Bristol-Myers Squibb‘s (BMY) arthritis medication Orencia, Eli Lilly‘s (LLY) new psoriasis medication and Valeants (VRX) Zyclara, an actinic keratosis skin cream, while also removing several names, including Pfizer‘s (PFE) arthritis drugs Xeljanz (it is now a preferred alternative follow price negotiations with Express Scripts).

Hot Low Price Stocks To Invest In 2019: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    ConocoPhillips (NYSE:COP) worked hard to turn its business around during the oil market downturn. We saw the first glimpse of its ability to thrive, now that prices are on the upswing, at the end of last year when the U.S. oil giant reported $545 million, or $0.45 per share, of adjusted earnings. That result marked a significant improvement from the loss it had posted in the previous year.

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short dropped to 17.34 million from the previous level of 18.27 million. Shares were trading at $68.71, within a 52-week range of $42.27 to $71.71.

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short dropped to 18.27 million from the previous level of 21.33 million. Shares were trading at $70.01 within a 52-week range of $42.27 to $71.71.

  • [By Matthew DiLallo]

    Oil prices have been on fire over the past year and recently topped $70 a barrel, which is the highest crude has been since late 2014. That rally in the oil market has helped fuel big-time gains in many oil stocks. Three that stand out are Anadarko Petroleum (NYSE:APC), Hess (NYSE:HES), and ConocoPhillips (NYSE:COP) because each has risen more than 20% this year. They might still have additional upside from here given that all three plan on spending billions of dollars to buy back more of their stock.

  • [By Garrett Baldwin]

    Eight Seconds… $1,260 Richer: Words can’t describe what you’ll see in this shocking footage – because you’ll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you’ll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…

    Three Stocks to Watch Today: COP, HD, HSBC
    ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government.
    Monday will be a quiet day on the earnings front. Investors are looking to Tuesday’s calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law.
    Expect a lot of chatter today about blockchain technology. That’s because ING Bank and HSBC Holdings Plc.(NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia.
    Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc.(Nasdaq: ITRI), Vipshop Holdings Ltd.(Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd.(Nasdaq: SKYS), Mazor Robotics Ltd.(Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd.(Nasdaq: MIME).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

  • [By Ethan Ryder]

    Whittier Trust Co. grew its holdings in ConocoPhillips (NYSE:COP) by 15.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 11,978 shares of the energy producer’s stock after acquiring an additional 1,635 shares during the period. Whittier Trust Co.’s holdings in ConocoPhillips were worth $710,000 at the end of the most recent reporting period.

Hot Low Price Stocks To Invest In 2019: A V Homes, Inc.(AVHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Evan Niu, CFA]

    Shares of AV Homes (NASDAQ:AVHI) have soared today, up by 29% as of 1:40 p.m. EDT, after the company announcedit was being acquired. Larger homebuilder Taylor Morrison Home Corporation (NYSE:TMHC) is scooping up AV Homes in a $1 billion deal.

Hot Low Price Stocks To Invest In 2019: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

Hot Low Price Stocks To Invest In 2019: Bazaarvoice, Inc.(BV)

Advisors’ Opinion:

  • [By Paul Ausick]

    BrightView Holdings Inc. (NYSE: BV) raised $469 million selling 21.3 million shares at $22, the low end of the expected range. Shares dropped 3% on the first day of trading and closed the week flat.

  • [By Paul Ausick]

    Below is Renaissance Capital’s list of the second quarter’s 10 largest IPOs ranked by deal size. We’ve also included the stock’s first-day pop (or decline) and its return as of the most recent close. Spotify Technology S.A. (NYSE: SPOT) is not included because its IPO was a direct offering that did not raise any new cash. Spotify shares popped nearly 13% on the April offering date, and the return to date is 27%.

    AXA Equitable Holdings Inc. (NYSE: EQH): $2.75 billion; first-day pop of 1.7%; return to date: 1.3% GreenSky LLC (NASDAQ: GSKY): $874 million: pop of 1.6%; return of 7.9% BJ’s Wholesale Club Holdings Inc. (NYSE: BJ): $638 million; pop and return of 29.4% DocuSign Inc. (NASDAQ: DOCU): $629 million; pop of 37.0%; return of 83.0% Pivotal Software Inc. (NYSE: PVTL): $555 million; pop of 5.0%; return of 71.0% GrafTech International Ltd. (NYSE: EAF): $525 million; decline of 3.7%; return of 23.0% BrightView Holdings Inc. (NYSE: BV): $469 million; decline of 2.7%; return of 2.7% Ceridian HCM Holding Inc. (NYSE: CDAY): $462 million; pop of 42.0%; return of 55.0% Essential Properties Realty Trust Inc. (NYSE: EPRT): $455 million; decline of 2.6%; return of 3.6% PluralSight Inc. (NASDAQ: PS): $311 million; pop of 33.0%; return of 61.0%

    Looking ahead to the third quarter, Renaissance Capital notes 65 companies currently in the IPO pipeline looking to raise $11 billion. Real estate firm Cushman & Wakefield is the both the largest potential IPO ($500 million) and the largest based on trailing 12-month sales ($7.23 billion). The pipeline is again heavy on health care offerings (11), industrials (five), financials (five) and, in a bit of a comeback, energy (four).

  • [By Chris Lange]

    BrightView Holdings Inc. (NYSE: BV) entered the market quietly in its initial public offering (IPO). The stock initially saw a slight gain compared to the announced pricing but quickly fell flat.

Hot Low Price Stocks To Invest In 2019: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get RXi Pharmaceuticals alerts:

    Intercellular Adhesion Molecule 1 Market Pipeline Review H1 Products in Clinical Stage, Methodology, therapeutic … (talkinvestor.com) Hypoxia Inducible Factor 1 Alpha Market Research Report H1: Drug Profile, Top Industry Intelligence and Therapeutic … (thestockanalysis.com) Connective Tissue Growth Factor Market Opportunities, Demands, Size, Share, Trends, Industry Sales Area and Its … (trueindustrynews.com) Global Connective Tissue Growth Factor Market 2018 Manufacturing Analysis and Development Forecast 2025 (trueindustrynews.com) Zacks: Analysts Expect RXi Pharmaceuticals Corp (RXII) to Announce -$0.56 EPS (americanbankingnews.com)

    Shares of RXi Pharmaceuticals stock traded down $0.04 on Tuesday, hitting $1.92. The company had a trading volume of 27,600 shares, compared to its average volume of 258,173. The stock has a market capitalization of $8.21 million, a PE ratio of -0.46 and a beta of 1.20. RXi Pharmaceuticals has a 52 week low of $1.90 and a 52 week high of $7.70.

  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get RXi Pharmaceuticals alerts:

    New Research Study on Connective Tissue Growth Factor Market 2018 to 2025 (morningoutlook.com) Hypoxia Inducible Factor 1 Alpha Market Pipeline Therapeutics H1, 2018 Product Description, Mechanism of Action … (exclusiveherald.com) Human Papillomavirus Associated Diseases Market Pipeline Therapeutics 2018 Drug Description, Target Finding, and … (thefreenewsman.com) Warts Market Therapeutic Pipeline H1, Drugs, Diagnostics, Vaccines and Preventive Technologies (newspublicist.com) Brokerages Anticipate RXi Pharmaceuticals Corp (RXII) to Post -$0.56 Earnings Per Share (americanbankingnews.com)

    Shares of RXi Pharmaceuticals traded down $0.01, hitting $2.24, on Tuesday, MarketBeat Ratings reports. 55,400 shares of the stock were exchanged, compared to its average volume of 275,015. The company has a market capitalization of $9.96 million, a price-to-earnings ratio of -0.53 and a beta of 1.15. RXi Pharmaceuticals has a one year low of $1.90 and a one year high of $7.70.

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Best Value Stocks To Invest In Right Now

New York, NY, based Investment company Standard General L.P. buys Turning Point Brands Inc during the 3-months ended 2018-03-31, according to the most recent filings of the investment company, Standard General L.P.. As of 2018-03-31, Standard General L.P. owns 4 stocks with a total value of $89 million. These are the details of the buys and sells.

Added Positions: NCMI, TPB,

For the details of Standard General L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.

These are the top 5 holdings of Standard General L.P.National CineMedia Inc (NCMI) – 14,387,113 shares, 83.65% of the total portfolio. Shares added by 8.59%Turning Point Brands Inc (TPB) – 455,319 shares, 9.92% of the total portfolio. Shares added by 49.13%CafePress Inc (PRSS) – 2,500,000 shares, 3.77% of the total portfolio. Emmis Communications Corp (EMMS) – 515,231 shares, 2.66% of the total portfolio. Added: Turning Point Brands Inc (TPB)

Standard General L.P. added to a holding in Turning Point Brands Inc by 49.13%. The purchase prices were between $19.44 and $22.38, with an estimated average price of $21.12. The stock is now traded at around $25.96. The impact to a portfolio due to this purchase was 3.27%. The holding were 455,319 shares as of 2018-03-31.

Best Value Stocks To Invest In Right Now: Meridian Bioscience Inc.(VIVO)

Advisors’ Opinion:

  • [By Logan Wallace]

    VIVO (CURRENCY:VIVO) traded down 0.1% against the dollar during the 24 hour period ending at 0:00 AM Eastern on May 8th. In the last seven days, VIVO has traded down 9.4% against the dollar. One VIVO coin can now be bought for about $0.77 or 0.00008506 BTC on major cryptocurrency exchanges including Cryptopia, CryptoBridge and Stocks.Exchange. VIVO has a market cap of $1.41 million and approximately $9,560.00 worth of VIVO was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Meridian Bioscience (VIVO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Intellia Therapeutics (NASDAQ: NTLA) and Meridian Bioscience (NASDAQ:VIVO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

Best Value Stocks To Invest In Right Now: Franklin Financial Network, Inc.(FSB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Franklin Financial Network (FSB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Franklin Financial Network Inc. (NYSE: FSB) was downgraded to sell from neutral at Compass Point. The stock has traded in a 52-week range of $30.30 to $42.65. The consensus price target for the company across Wall Street is $37.80. The stock closed Monday at $39.40, a rise of more than 5%.

  • [By Stephan Byrd]

    ValuEngine lowered shares of Franklin Financial Network (NYSE:FSB) from a hold rating to a sell rating in a research report sent to investors on Monday.

  • [By Max Byerly]

    Franklin Financial Network (NYSE:FSB) was downgraded by research analysts at Compass Point from a “neutral” rating to a “sell” rating in a research note issued on Tuesday, The Fly reports.

Best Value Stocks To Invest In Right Now: Blackrock Health Sciences Trust(BME)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of B&M European Value Retail SA (LON:BME) have earned an average recommendation of “Buy” from the sixteen ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is GBX 442.92 ($5.90).

  • [By Max Byerly]

    B&M European Value Retail (LON:BME) had its target price boosted by analysts at HSBC from GBX 470 ($6.26) to GBX 500 ($6.66) in a report released on Wednesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.54% from the company’s current price.

Best Value Stocks To Invest In Right Now: Finisar Corporation(FNSR)

Advisors’ Opinion:

  • [By Anders Bylund]

    Finisar(NASDAQ:FNSR) followed in AAOI’s footsteps in March, surging more than 10% higher around the announcement of Lumentum’s Oclaro deal, but losing it all amid deafening radio silence. By the end of March, the stock had fallen 12.2% lower, and Finisar has not enjoyed any glowing analyst analyses in April.

  • [By Ezra Schwarzbaum]

    Finisar Corporation (NASDAQ: FNSR) was up 2.9 percent Monday morning. The stock had fallen 4 percent on the Commerce Department news in April.

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

  • [By Anders Bylund]

    The maker of optical networking components was off to a good start in March, but it lost all momentum when rival Finisar (NASDAQ:FNSR) reported weak earnings with mellow management comments on the state of the optical market. Finisar shares plunged 23% lower the next day, dragging Oclaro down in a 13% three-day slide.

Best Value Stocks To Invest In Right Now: Enbridge Inc(ENB)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Enbridge (NYSE:ENB) has hit a rough patch in recent years. While cash flow and its dividend have continued rising, shares have slumped about 20% since the start of 2018 and are down more than 40% from their peak in 2015. Because of that, Enbridge’s valuation has declined to a very inexpensive level, which when combined with a steady stream of dividend increases, has pushed its yield up to an eye-catching 6.7%. That high yield for a cheap price makes Enbridge look like a compelling stock to buy, especially considering all the growth it has coming down the pipeline.

  • [By Matthew DiLallo]

    Several high-yielding dividend stocks have taken it on the chin this year due to a sell-off in the stock market and rising interest rates. That one-two punch has hit pipeline stocks the hardest, with several top-notch companies tumbling by a double-digit percentage since the start of the year. Three that stand out as excellent options to consider buying now that they’re on sale are Magellan Midstream Partners (NYSE:MMP), Antero Midstream Partners (NYSE:AM), and Enbridge (NYSE:ENB).

  • [By Matthew DiLallo]

    Last November, Enbridge (NYSE:ENB) outlined its three-year strategic and financial plan. One of the key components of the Canadian pipeline giant’s strategy was selling 3 billion Canadian dollars’ ($2.3 billion as of May 9, 2018) worth of non-core assets in 2018, which would give it some of the cash needed to finance its CA$22 billion ($17 billion) expansion plan. That would enable the company to reduce debt while still growing cash flow and the dividend at a 10% compound annual rate through 2020.

  • [By Matthew DiLallo]

    Oil prices have improved dramatically over the past year as OPEC’s move to drain off the supply glut proved more successful than envisioned. That rising tide has lifted most oil stocks. However, that doesn’t mean investors have missed the boat, since many oil stocks still have ample upside. Two top ones where that’s the case are Devon Energy (NYSE:DVN) and Enbridge (NYSE:ENB).

  • [By Paul Ausick]

    Calgary-based energy infrastructure company Enbridge Inc. (NYSE: ENB) on Thursday made a nonbinding offer to acquire the approximately 17% of Spectra Energy Partners L.P. (NYSE: SEP) it does not already own in a deal that would pay unitholders of Spectra 1.0123 shares of Enbridge common stock for every common unit of Spectra they currently hold.

Best Value Stocks To Invest In Right Now: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Shane Hupp]

    Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

  • [By Stephan Byrd]

    Media stories about CELLECT BIOTECH/S (NASDAQ:APOP) have been trending somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CELLECT BIOTECH/S earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.3583768207142 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.